Programme

ADVANCES IN GYNECOLOGIC ONCOLOGY

XXVIII National Congress SIOG

MILAN, 22/23 JUNE  2017
Istituto Nazionale dei Tumori – Aula Magna G. Bonadonna

Download Program

THURSDAY JUNE 22ND, 2017                                                
9:00- 9:05
Welcome                                                                                               

F. Raspagliesi

9:05 – 9:25 
MAGISTRAL LECTURES  
Independent research in Italy with the new European decree


F. Perrone

9:25 – 9:45
Sustainability of cancer treatment in the coming years

S. Pecorelli  
9:45 – 10:15    COFFEE BREAK
Pro & Cons in Gynecologic  Oncology 
Session – “Early” Stage Ovarian Cancer
Chairmen: M. Franchi – N. Biglia - N. Cormio
10:15 – 10:55
Incomplete surgery
o   Surgery pro                                                              
o   Chemo pro                                                                                                
o   Take Home Messages    



L. Bocciolone
A. Gadducci
E. Sartori

10:55 – 11:40
Fertility sparing treatment and patient selection:
o   the surgeon point of view                                                    
o   the oncologist point of view                                     
o   the reproductive medicine specialist point of view 



A. Ditto
G. Mangili
E. Somigliana

11:40 – 11:55
Translational  research  and  Perspective  


D. Mezzanzanica

11:55 – 12:05
Discussion
Session - Ovarian Cancer–Stage III-IV treatment in 2017

Chairmen: F. Raspagliesi – C. Zamagni - P. Scollo

12:05 – 12:25
Operability decision and surgical goals of cytoreduction surgery


A. Du Bois

12:25 – 12:50                                                                                         
o     the Primary surgery vs NACT: 
role of laporoscopy                                             
o     Take Home Messages 


G. Scambia

F. Raspagliesi

12:50 – 13:05
Frailty and Surgical Complexity score in the decision making process


G. Aletti

13:05 – 14:05       LUNCH
Session - Ovarian Cancer–Hot Topics in Surgical Treatment
Chairmen: F. Raspagliesi – C. Zamagni - P. Scollo
14:05 – 14:20
Secondary Cytoreduction is the new standard?

A. Du Bois
14:20 – 15: 00
HIPEC
o   Pro                                                                                       
o   Cons                                                                                   
o   Take home message     



A. Fagotti
J. Sehouli
P. De Iaco

15:00 – 15:10
Discussion
Session - Ovarian Cancer– Hot Topics in Medical Treatment

Chairmen: S. Pignata – D. Lorusso - D. Katsaros

15:10 – 15:25
Beva  Maintenance Therapy - In high risk patients or according to the label ? 


N. Colombo

15:25 – 16:05
The Parp Inhibitors era:
o   For BRCA mutated patients                                    
o   For all comers                                                                     
o   Take  Home  Messages    


E. P. Lauraine
M. R. Mansoor
D. Lorusso

16:05 – 16:35
Treatment of recurrences beyond platinum 
Treatment algorithm: the changing landscape

S. Pignata
I. R. Coquard
16:35 – 16:45                      
Discussion

17:00 – 17:30
ASSEMBLEA ANNUALE SOCI SIOG
FRIDAY JUNE 23RD, 2017
Session - Uterine cancer  

Chairmen: T. Maggino – G. Salerno –  P. Casali 

8:30 – 8:45
Mini-invasive surgery: focus on feasibility, morbidity and costs 

F. Ghezzi
8:45 – 9:25
Is sentinel node detection the new standard in nodal status evaluation?
o   Pro                                                                                                   
o   Cons                                                                                                
o   Take home message                     


F. Martinelli
F. Zullo
A. Buda
9:25 – 9:35
Discussion
9:35 – 10:15
High Risk uterine confined endometrial cancer –  Adjuvant treatment
o   RT                                                                                        
o   Chemotherapy                                                                    
o   Take  Home  Messages


V. Valentini
A. Oaknin
A. M. Cerrotta
10:15 – 10:25
Discussion
10:25 – 10:40
How could endometrial cancer treatment change in the light of the ongoing trials?

S. Greggi
10:40 – 10.55                                                                                           
Update in sarcoma treatment 

G. Grignani 
10:55 – 11:25 COFFEE BREAK
Session - Cervical cancer

Chairmen: R. Angioli – M. G. Ferrandina - E. Vizza

11:25 – 11:40
Role of HPV vaccines in Cervical Cancer – Prevention and treatment    

G. Bogani
11:40 – 12:25
Treatment in stage IB1
o   Conservative options                                                                            
o   Non conservative options                                                          
o   Sedlis criteria for adjuvant treatment: are they still working?  


F. Landoni
F. Raspagliesi
I. Palaia
12:25 – 12:35
Discussion
12:35 – 13:20
o   Locally advanced Disease role of chemotherapy                                
o   Is adenocarcinoma really a different entity                                           
o   Perspective in cervical cancer treatment       

R. Angioli
M. Signorelli
C. Marchetti
13:20 – 13:30
Discussion
13:30 – 14:30 LUNCH
KEY LECTURES 
14:30 -14:45
Complimentary medicine for the oncologic patient: clinical evidence


E. Rossi 
14:45 -15:00
Reduction of adverse effects of anticancer therapies and improvement of the quality of life of the oncologic patient 



E. Rossi 
15:00 -15:15
Nutrition and prognosis in oncologic patients

A. Mascheroni
15:15 -15:30
Closing remarks and CME test